Navigation Links
Researchers at IRB Barcelona produce more data on key genes in diabetes
Date:11/19/2008

me, a study has shown that another gene, called Mitofusin 2 (Mfn2), which is decreased in diabetic patients, is also controlled by PGC1-beta. This information is highly relevant because until now it was considered that PGC1-beta controlled the production of energy only by regulating the expression of mitochondrial genes responsible for oxidative phosphorylation. "We have discovered what the cell does to regulate this mitochondrial fusion gene and we explain why this gene is decreased in diabetes, as it is regulated by PGC1-beta, which in turn is affected by this disease. However, although this evidence allows us to propose interesting hypotheses as to the role of Mfn2, its exact role remains unknown", explains the first author of the study, Marc Liesa.

Key or secondary role in diabetes?

One of the hypotheses is that mitochondrial fusion is crucial for the correct function of these organelles and when the gene that regulates this fusion is decreased, the function of mitochondria is also impaired. But where is Mfn2 situated in the genetic map of diabetes? Is the decrease in mitochondrial fusion related directly to the appearance of insulin resistance? The researchers have obtained the first data that support the notion that Mfn2 plays a key role.

In 2005, in experiments in vitro using rat skeletal muscle cells, the scientists removed the expression of only the Mfn2 gene without touching PGC1-beta, and confirmed that the decrease in mitochondrial fusion affected the capacity to generate energy, "regardless of whether PGC1-beta is functioning correctly", stresses the head of the group, Antonio Zorzano. "What we are proposing is that the alteration in the fusion alters mitochondrial activity. Observation that the removal of only Mfn2 produces insulin resistance in later experiments in a simple living model not only in individual cells - , would imply that modulation of this gene contributes to this pathology, thereby making Mfn2 a the
'/>"/>

Contact: Sonia Armengou
sonia.armengou@irbbarcelona.org
34-934-037-255
Institute for Research in Biomedicine (IRB Barcelona)
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Pitt researchers use fluorescence to develop method for detecting mercury in fish
2. Caltech researchers get first 3-D glimpse of bacterial cell-wall architecture
3. Mayo researchers identify dangerous two-faced protein crucial to breast cancer spread and growth
4. Researchers find link between nicotine addiction and autism
5. UI researchers help to improve carbon measurements in global climate studies
6. Space researchers developing tool to help disoriented pilots
7. Montana State researchers receive grant to study algae as a source of biofuel
8. Einstein researchers develop a new way to study how breast cancer spreads
9. Queens University Belfast researchers trace octopuses family tree
10. UD researchers show that plants can accumulate nanoparticles in tissues
11. Clemson researchers advance nano-scale electromechanical sensors

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers at IRB Barcelona produce more data on key genes in diabetes
Researchers at IRB Barcelona produce more data on key genes in diabetes
(Date:11/6/2009)... To celebrate the 150th anniversary this month of ...merican Institute of Biological Sciences (AIBS) is... about Charles Darwin and his historic insights in...ian of the University of California, Berkeley, and...dian,s article, "Ten Myths About Charles Darwin," ...
(Date:11/6/2009)... PHILADELPHIA (November 06, 2009) The Monell Cent...o-hosts of the Beijing International Meeting on Ta...laboration with the CAS, the meeting will be the f...e held in China. , Alan Leshner, Chief Executive... of Science and Executive Publisher of Science mag...
(Date:11/5/2009)... Kent State University has been awarded a training... Science Foundation under its Integrative Graduati.... This is the first IGERT grant to be awarded to K...erican Recovery and Reinvestment Act of 2009, runs...t that focuses on environment aquatic resource sen...
Breaking Biology News(10 mins):Monell Center joins with CAS to host Beijing meeting on taste and smell research 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2Hospira Names Daphne E Jones Chief Information Officer 5611 1Hospira Names Daphne E Jones Chief Information Officer 5611 2Verizon Health Care Experts to Address 2009 Connected Health Symposium in Boston on Oct 21 59823 1Verizon Health Care Experts to Address 2009 Connected Health Symposium in Boston on Oct 21 59823 2Inverness Medical Innovations Schedules Conference Call for 10 3A00 a m ET October 27 2009 to Discuss Third Quarter 2009 Results 14544 1Inverness Medical Innovations Schedules Conference Call for 10 3A00 a m ET October 27 2009 to Discuss Third Quarter 2009 Results 14544 2
...with separate sexes, embryos commit to becoming ma...cision is made by sex determination genes on the s...lopment have changed remarkably little during evol...nd the sex chromosomes themselves are among the mo...research team formed by Sander van Doorn (Santa Fe...
...ional team of Australian and Israeli researchers h...e biggest moonlight sex event on Earth., An ancien...chers from the ARC Centre of Excellence for Coral ...gger for the annual mass spawning of corals across...ias Great Barrier Reef, shortly after a full moon....
... in mice of immune cells that promote the formatio...s for endometriosis, a painful condition associate...f women of reproductive age. , The formation of ...courage the growth of tumors and endometriosis les...arch associate in the Vascular Biology Program at ...
Other Biology News:A new explanation for evolutionary changes in genetic sex-determination systems 2Key found to moonlight romance 2Key found to moonlight romance 3Immune cells promote blood vessel formation in mouse endometriosis 2
(Date:11/6/2009)..., Nov. 6 BioSpecifics Te...ical company developing first-in-class collagenase...ults for the third quarter ended September 30, 200...ber of this year, the FDA,s Arthritis Advisory Com... the approval of XIAFLEX(TM) for the treatment of ...
(Date:11/6/2009)... Calif., Nov. 6 Calbiotech, Inc. a...siness Innovative Research (SBIR) Phase I contract...mmand. Under terms of the agreement, Calbiotech wi...e diagnosis of Dengue virus. ,, Dengue virus...ajor threat to military forces deployed to tropica...
(Date:11/5/2009)...Md., Nov. 5 GenVec, Inc....sults for the third quarter ended September 30, 20....04 per share) for the three months ended Septembe...($0.08 per share) in the comparable quarter of 200...enVec,s net loss was $14.1 million ($0.15 per shar...
(Date:11/5/2009)...l on Thursday, November 5, 2009 at 4:30 p.m. Easte...RNewswire-FirstCall/ - OncoGenex Pharmaceuticals, ... ) today reported unaudited financial results for ...30, 2009 and reviewed the Company,s highlights for...nsolidated results reflect the operations of OncoG...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8
...ident and CEO of the University of Wisconsin Medic...irs for UW Medical School was the kick-off speaker...s interview with WTN, Dr. Grossman discusses how a... data but, at the same time a Knowledge Gap betwee...rd certified in internal medicine, pulmonary disea...
...hnology Network sat down with Tom Still, the presi...cuss the basic tenets of the organization and init... Wisconsins technology space grow. Read Part One. ...biggest challenges the Wisconsin Technology Counci...plishments? , ,Tom Still: The greatest accomplish...
...it is in chains. Fail to develop the talents of an...ury wealth. This quotation is taken from Tony Blai...K, in 1999. It opens chapter one of The Mismanagem...tive forthcoming book by British HR researchers An... ,The main focus of their research was on how univ...
Other Biology Technology:WTN interview: Dr. Jeffrey Grossman, CEO UW Medical Foundation 2WTN interview: Dr. Jeffrey Grossman, CEO UW Medical Foundation 3WTN interview: Dr. Jeffrey Grossman, CEO UW Medical Foundation 4WTN interview: Dr. Jeffrey Grossman, CEO UW Medical Foundation 5WTN exclusive interview with Tom Still, Wisconsin Technology Council - Part 2 2WTN exclusive interview with Tom Still, Wisconsin Technology Council - Part 2 3WTN exclusive interview with Tom Still, Wisconsin Technology Council - Part 2 4Talent Mismanagement 2Talent Mismanagement 3
Mouse/Rat Anti-Canine CD3 / CD4 Dual Colour Reagent Antibody, FITC / R-Phycoerythrin Conjugated from AbD Serotec
4',6-diamidino-2-phenylindole, dihydrochloride (DAPI) *FluoroPure™ grade* from Molecular Probes (Invitrogen)
Essential Techniques: Gel Electrophoresis: Proteins from Promega
Colloids and Interfaces with Surfactants and Polymers an Introduction. Jim Goodwin. Wiley (2004); 296 pages soft cover from Invitrogen
Biology Products: